IL33 and colorectal carcinoma: Recently, a link was reported between inflammation (more specifically the IL-33/ST2L axis) and CRC progression, including the promotion of intestinal polyposis, the progression of colorectal adenoma to carcinoma and the enhancement of metastasis22, 23, 24, 25.